Cargando…
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
Fibrosing ILDs can develop a progressive phenotype and are described under the terminology PF-ILDs. Due to commonalities with IPF, the potential efficacy and tolerability of antifibrotic drugs pirfenidone and nintedanib are currently evaluated in PF-ILDs. http://bit.ly/2koL0A4
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488849/ https://www.ncbi.nlm.nih.gov/pubmed/31578213 http://dx.doi.org/10.1183/16000617.0109-2019 |